3 documents found, page 1 of 1

Sort by Issue Date

The GO-DACT protocol

Vieira de-Sousa, Elsa; Canhão, Helena; Alves, P.; Maria Rodrigues, Ana; Teixeira, F.; Tavares-Costa, J.; Bernardo, A.; Pimenta, S.

The GO-DACT is an investigator-initiated, multicentric randomized placebo-controlled double-blinded trial, that assesses dactylitis as primary endpoint. Psoriatic arthritis patients naïve to methotrexate and biologic disease modifying anti-rheumatic drugs, with at least one active dactylitis, were assigned to golimumab in combination with methotrexate or placebo in combination with methotrexate, for 24 weeks. B...


Portuguese recommendations for the prevention, diagnosis and management of prim...

Maria Rodrigues, Ana; Canhão, Helena; Marques, A.; Ambrosio, C.; Borges, J.; S. Coelho, Pedro; Costa, L.; Fernandes, S.; Goncalves, I; Goncalves, M. J.


Spectrum of ankylosing spondylitis in Portugal. Development of BASDAI, BASFI, B...

M. Pimentel-Santos, F.; Mourão, Ana Filipa; Ribeiro, Célia; Costa, J. A.; Santos, Helena; Barcelos, A.; Pinto, Patricia; Godinho, F.; Cruz, Margarida

The availability of population-specific normative data regarding disease severity measures is essential for patient assessment. The goals of the current study were to characterize the pattern of ankylosing spondylitis (AS) in Portuguese patients and to develop reference centile charts for BASDAI, BASFI, BASMI and mSASSS, the most widely used assessment tools in AS. AS cases were recruited from hospital outpatie...


3 Results

Queried text

Refine Results

Author





















Date



Document Type


Access rights


Resource


Subject